Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism
Roberto Arriga(University of Rome Tor Vergata), Davide Lauro(University of Rome Tor Vergata), Nicola Di Daniele(University of Rome Tor Vergata), David Della‐Morte(Unknown), Maria Giovanna Scioli(University of Rome Tor Vergata), Manfredi Tesauro(University of Rome Tor Vergata), Paolo Sbraccia(University of Rome Tor Vergata), Aikaterini Andreadi(University of Rome Tor Vergata), Augusto Orlandi(University of Rome Tor Vergata), Donatella Pastore(University of Rome Tor Vergata), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Francesca Pacifici(University of Rome Tor Vergata), Giulia Donadel(University of Rome Tor Vergata), Andrea Coppola(University of Rome Tor Vergata), Barbara Capuani(University of Rome Tor Vergata), Alfonso Bellia(University of Rome Tor Vergata)
Cited by 39
Related Papers
Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
|The American Journal of Human Genetics|2002|534
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
|Oncotarget|2016|326
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
|Journal of Clinical Medicine|2020|252